Thursday, May 12, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Mortality among hospitalized Iranian COVID-19 patients during Alpha and Delta waves

by Medical Finance
in Coronavirus
Study: Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants. Image Credit: UfzBizPhoto / Shutterstock.com
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV‐2), which is the causal agent of the coronavirus disease 2019 (COVID-19), has infected over 464 million worldwide and caused almost 6.1 million deaths. In Iran, SARS-CoV-2 has infected over 7.1 million people and caused almost 140,000 deaths.

In a new study under consideration at Scientific Reports and published on the Research Square* preprint server, scientists analyze the death proportion and risk of death among COVID-19 hospitalized patients over time and during different waves of the pandemic.

Study: Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants. Image Credit: UfzBizPhoto / Shutterstock.com

Study: Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants. Image Credit: UfzBizPhoto / Shutterstock.com

Background

SARS-CoV-2 infection could lead to asymptomatic or mild cases, moderate or severe conditions, and even death. Predictors of severe outcomes include age, male sex, and the presence of comorbidities such as hypertension, diabetes, and cardiac disease.

Several SARS-CoV-2 variants have emerged, with the World Health Organization (WHO) defining these variants according to their increased transmissibility and virulence.

In the current study, researchers analyzed the Alpha (B.1.1.7) and Delta (B.1.617.2) SARS-CoV-2 variants. The Alpha variant was first detected in England in November 2020, while the Delta variant was first reported in India in December 2020.

The SARS-CoV-2 Delta variant is more transmissible than previous SARS-CoV-2 strains, as it is associated with an increased risk of hospitalization, intensive care unit (ICU) admission, and death. However, the trend of mortality due to the Delta variant around the world is quite varied and difficult to describe. This could be due to a number of factors, such as hospital load and the presence of underlying medical conditions of patients.

Studying the COVID-19 mortality rate could help healthcare workers quickly identify at-risk patients. To address this issue, scientists conducted a multicenter study in Tehran, Iran to assess the proportion of deaths and risk of death among COVID-19 hospitalized patients.

Study findings

The current observational study involving hospitalized COVID-19 patients in Tehran province was conducted between March 21, 2021, and October 3, 2021. During this period, researchers analyzed two peaks associated with the Alpha and Delta variants.

Patients during the second peak were more likely to be female and above 60 years of age. The death proportion of patients admitted to the ICU peaked in April and August of 2021. Scientists also observed that the mortality rate decreased with gender and age, whereas it increased with comorbidities.

The death proportion among patients infected with the Delta variant was lower than those infected with the Alpha variant. The second peak was associated with a higher risk of death. Taken together, these findings correlate with previous reports on death and hospitalization rates during both Alpha and Delta variant-driven surges.

A debatable issue is the reduction of the death proportion from the first to the second peak in this study and an increased risk of COVID-19 death. This could be due to the number of patients admitted during the second peak that increased rapidly, while deaths increased gradually. A second contributing factor could be the start of the vaccination program in Iran in May 2021. During this time, the death proportion in the younger age group decreased, despite the vaccination rate not being high in this group.

A higher death proportion and risk of COVID-19 death were observed among ICU patients during the Delta wave as compared to the Alpha wave. The mean number of comorbidities, mean age and fraction of males were lower in the Delta wave, which may be due to the higher severity and fatality rate associated with the Delta variant.

A significant difference was reported in the death proportion among ICU patients in different counties of Tehran. This difference could be driven by several factors, such as the nutritional status of the patient and the skill of the intensivist physician.

Additionally, during the Delta wave, ICU bed shortages were more common in some counties, thus causing patients to wait for several hours to several days before being admitted, ultimately contributing to more deaths.

Conclusions

In the current study, the death proportion was found to decline from March 2021 to October 2021; however, hospitalization and risk of COVID-19 death increased during this time period. Furthermore, the Delta wave led to a higher risk of death as compared to the Alpha wave.

Some of the factors associated with the high mortality rate in the Delta surge in Iran were identified to be burnout among healthcare workers, as well as hospital bed, ICU space, and medical supply shortages.

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:

  • Zali, A., Hodadoost, M., Gholamzadeh, S., et al. (2022). Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants. Research Square. doi:10.21203/rs.3.rs-1333217/v1.
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England. Image Credit: Angel Soler Gollonet / Shutterstock.com

How much protection does SARS-CoV-2 infection provide against reinfection?

by Medical Finance
May 12, 2022
0

In a recent study published on the medRxiv* preprint server, researchers determine whether previous severe acute respiratory syndrome coronavirus 2...

Study: Identifying SARS-CoV-2 regional introductions and transmission clusters in real time. Image Credit: Dotted Yeti/Shutterstock

Researchers develop a website to identify SARS-CoV-2 regional clusters in real-time

by Medical Finance
May 12, 2022
0

In a recent study posted to the medRxiv* pre-print server, a team of researchers developed a phylogenetics-based website to identify...

Study: Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study. Image Credit: wavebreakmedia / Shutterstock.com

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

by Medical Finance
May 12, 2022
0

In a recent prospective study published on the medRxiv* preprint server, researchers examine the effects of disease-modifying therapies (DMTs) implemented...

Study: Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children. Image Credit: anon_tae/Shutterstock

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

by Medical Finance
May 12, 2022
0

A recent study posted to the medRxiv* preprint server predicted the efficacy of the SOBERANA 02 and SOBERANA Plus coronavirus...

Study: The impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Image Credit: Kateryna Kon / Shutterstock.com

How did the COVID pandemic affect the spread of other zoonotic diseases?

by Medical Finance
May 12, 2022
0

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been speculated about in different ways since it first...

Study: Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. Image Credit: solar22/Shutterstock

Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

by Medical Finance
May 12, 2022
0

Mar 8 2022 A recent study posted to the medRxiv* preprint server assessed neutrophil extracellular trap (NET) formation and antiviral host...

Next Post
Study: Reactive and acute inflammatory microvasculopathy in 36 COVID-19 autopsy brains. Image Credit: boscorelli/Shutterstock

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

Study: Modelling the within-host spread of SARS-CoV-2 infection, and the subsequent immune response, using a hybrid, multiscale, individual-based model. Part I: Macrophages. Image Credit: MedMoMedia/Shutterstock

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar. Image Credit: hedgehog94/Shutterstock
    Natural infection versus messenger RNA vaccination-induced immune protection
  • Study: Usefulness of real-time RT-PCR to understand the kinetics of SARS-CoV-2 in blood: a prospective study. Image Credit: Vector-3D/Shutterstock
    Study explores SARS-CoV-2 viremia kinetics
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply